Health outcomes of children during their first year of life after in utero exposure to immunosuppressive drugsResearch Project | 01.12.2024 - 30.11.2025 Imported from Grants Tool 4705652FundingHealth outcomes of children during their first year of life after in utero exposure to immunosuppressive drugsForschungsfonds (Excellent Junior Researcher) (GrantsTool), 12.2024-11.2025 (12) PI : Mack, Ines.CI : Aghlmandi, Soheila,Bielicki, Julia Anna.Members (3)Ines MackPrincipal InvestigatorSoheila AghlmandiCo-Investigator Julia Anna BielickiCo-InvestigatorResearch Groups[FG] Basel Institute for Clin. Epidem. & Biostat. (CEB) Research Group Julia Anna Bielicki
Health outcomes of children during their first year of life after in utero exposure to immunosuppressive drugsResearch Project | 01.12.2024 - 30.11.2025
FundingHealth outcomes of children during their first year of life after in utero exposure to immunosuppressive drugsForschungsfonds (Excellent Junior Researcher) (GrantsTool), 12.2024-11.2025 (12) PI : Mack, Ines.CI : Aghlmandi, Soheila,Bielicki, Julia Anna.
Health outcomes of children during their first year of life after in utero exposure to immunosuppressive drugsForschungsfonds (Excellent Junior Researcher) (GrantsTool), 12.2024-11.2025 (12) PI : Mack, Ines.CI : Aghlmandi, Soheila,Bielicki, Julia Anna.
Members (3)Ines MackPrincipal InvestigatorSoheila AghlmandiCo-Investigator Julia Anna BielickiCo-Investigator
Research Groups[FG] Basel Institute for Clin. Epidem. & Biostat. (CEB) Research Group Julia Anna Bielicki